Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Metformin – Forschungsarchiv – Seite 8 von 24 | SupStack

Metformin – Forschungsarchiv

Studien 1301–1350 von 2110, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

1301RCT2013

Zhang TX, Xu JX, Peng F, Chai DJ, Lin JX · Blood Press (2013)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Metformin – Forschungsarchiv

Metformin reduces vascular endothelial dysfunction caused by an acute glucose load in patients with hypertension.

Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.

Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.

Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial.

Efficacy of combined metformin-letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome.

Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease.

[Decrease of liver fat content by aerobic exercise or metformin therapy in overweight or obese women].

Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus.

Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance.

The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose.

A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.

Metformin vs insulin in the management of gestational diabetes: a meta-analysis.

Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial.

Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults.

Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.

Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS).

Association of metformin use with cancer incidence and mortality: a meta-analysis.

Gender-dependent effects of metformin on vaspin and adiponectin in type 2 diabetes patients: a randomized clinical trial.

The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.

Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.

Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.

Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: a randomized clinical trial.

Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials.

Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes.

Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone.

Metformin in obese children and adolescents: the MOCA trial.

Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial.

Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome.

Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review.

The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis.

Metformin treatment in different phenotypes of polycystic ovary syndrome.

Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy.

Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.

Randomized trial of metformin vs insulin in the management of gestational diabetes.

Efficacy of metformin versus insulin in the management of pregnancy with diabetes.

Treatment effects on measures of body composition in the TODAY clinical trial.

Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.

Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance.

Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.

Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.

Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment.

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.

Systematic review of metformin use in obese nondiabetic children and adolescents.

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.